EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11 | +10.0% | 476 | -8.1% | 0.00% | – |
| Q2 2023 | $10 | +100.0% | 518 | +108.9% | 0.00% | – |
| Q1 2023 | $5 | +66.7% | 248 | +28.5% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 193 | -11.5% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 218 | +772.0% | 0.00% | – |
| Q2 2022 | $1,000 | -95.7% | 25 | -98.1% | 0.00% | – |
| Q3 2019 | $23,000 | -17.9% | 1,308 | 0.0% | 0.00% | – |
| Q2 2019 | $28,000 | +1300.0% | 1,308 | +262.3% | 0.00% | – |
| Q3 2015 | $2,000 | -92.3% | 361 | -96.4% | 0.00% | – |
| Q1 2015 | $26,000 | +85.7% | 10,000 | 0.0% | 0.00% | – |
| Q4 2014 | $14,000 | -53.3% | 10,000 | -50.0% | 0.00% | – |
| Q3 2014 | $30,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |